Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection (GS-US-380-1489): a double-blind, multicentre, phase 3, randomised controlled non-inferiority trial.

.

BACKGROUND: Integrase strand transfer inhibitors (INSTIs) are recommended

PMID: 28867497

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.